"Ankyrins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of membrane-associated proteins responsible for the attachment of the cytoskeleton. Erythrocyte-related isoforms of ankyrin attach the SPECTRIN cytoskeleton to a transmembrane protein (ANION EXCHANGE PROTEIN 1, ERYTHROCYTE) in the erythrocyte plasma membrane. Brain-related isoforms of ankyrin also exist.
| Descriptor ID |
D017487
|
| MeSH Number(s) |
D12.776.543.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ankyrins".
Below are MeSH descriptors whose meaning is more specific than "Ankyrins".
This graph shows the total number of publications written about "Ankyrins" by people in this website by year, and whether "Ankyrins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ankyrins" by people in Profiles.
-
Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease. Am J Hematol. 2021 08 01; 96(8):E288-E291.
-
Putative role of Brugada syndrome genes in familial atrial fibrillation. Eur Rev Med Pharmacol Sci. 2019 Sep; 23(17):7582-7598.
-
AnkG hemizygous mice present cognitive impairment and elevated anxiety/depressive-like traits associated with decreased expression of GABA receptors and postsynaptic density protein. Exp Brain Res. 2017 11; 235(11):3375-3390.
-
Gene-Targeted Analysis of Clinically Diagnosed Long QT Russian Families. Int Heart J. 2017 Feb 07; 58(1):81-87.
-
Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs. Cancer Res. 2007 Jan 15; 67(2):626-33.